SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-185602
Filing Date
2022-06-30
Accepted
2022-06-30 07:59:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d341556d424b5.htm 424B5 278921
2 GRAPHIC g341556g01g01.jpg GRAPHIC 35431
3 GRAPHIC g341556g04a00.jpg GRAPHIC 36552
  Complete submission text file 0001193125-22-185602.txt   370497
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-244401 | Film No.: 221056541
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences